Abstract
Congestive heart failure is defined as the inability of the heart to meet the metabolic demands of the body or else to meet these demands only in the setting of an abnormally elevated filling pressure. The clinical presentation of a patient with heart failure is variable and depends on the degree of compensation. Heart failure is often a result of myocardial failure but may also occur in the presence of near-normal cardiac function under conditions of extremely high demand. Irrespective of etiology, the end result of heart failure is circulatory failure. This chapter will provide an overview of mechanisms, diagnostic tools, and management of cardiac failure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ross J Jr, Braunwald E (1964) Studies on Starling’s law of the heart. IX. The effects of impeding venous return on performance of the normal and failing human left ventricle. Circulation 30:719–727
Quinones MA, Gaasch WH, Alexander JK (1976) Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man. Circulation 53(2):293–302
Ross J Jr (1983) Mechanisms of cardiac contraction. What roles for preload, afterload and inotropic state in heart failure? Eur Heart J 4(Suppl A):19–28
Grossman W, Braunwald E, Mann T, McLaurin LP, Green LH (1977) Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations. Circulation 56(5):845–852
Suga H, Kitabatake A, Sagawa K (1979) End-systolic pressure determines stroke volume from fixed end-diastolic volume in the isolated canine left ventricle under a constant contractile state. Circ Res 44(2):238–249
Thomas JA, Marks BH (1978) Plasma norepinephrine in congestive heart failure. Am J Cardiol 41(2):233–243
Cody RJ (1997) The sympathetic nervous system and the renin-angiotensin-aldosterone system in cardiovascular disease. Am J Cardiol 80(9B):9J–14J
Curtiss C, Cohn JN, Vrobel T, Franciosa JA (1978) Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 58(5):763–770
Lee MA, Bohm M, Paul M, Ganten D (1993) Tissue renin-angiotensin systems. Their role in cardiovascular disease. Circulation 87(5 Suppl):IV7–IV13
Dzau VJ (1993) Local contractile and growth modulators in the myocardium. Clin Cardiol 16(5 Suppl 2):II5–II9
Cohn JN (1995) Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation 91(10):2504–2507
Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R et al (1986) Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 59(3):297–309
Ratajska A, Campbell SE, Sun Y, Weber KT (1994) Angiotensin II associated cardiac myocyte necrosis: role of adrenal catecholamines. Cardiovasc Res 28(5):684–690
Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341(8):577–585
Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347(3):161–167
Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA et al (1997) Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350(9088):1349–1353
Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L et al (2001) Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37(2):379–385
Colucci WS (1997) Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 80(11A):15L–25L
Ross RD, Bollinger RO, Pinsky WW (1992) Grading the severity of congestive heart failure in infants. Pediatr Cardiol 13(2):72–75
Yoshibayashi M, Kamiya T, Saito Y, Nakao K, Nishioka K, Temma S et al (1995) Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 133(2):207–209
Law YM, Keller BB, Feingold BM, Boyle GJ (2005) Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 95(4):474–478
Nir A, Nasser N (2005) Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 11(5 Suppl):S76–S80
Grantham JA, Burnett JC Jr (1997) BNP: increasing importance in the pathophysiology and diagnosis of congestive heart failure. Circulation 96(2):388–390
de Lemos JA, McGuire DK, Drazner MH (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362(9380):316–322
Lauer B, Schannwell M, Kuhl U, Strauer BE, Schultheiss HP (2000) Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 35(1):11–18
Eronen M, Siren MK, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T (2000) Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 106(1 Pt 1):86–91
Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N et al (2001) Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 37(1):238–242
Udink ten Cate FE, Breur JM, Cohen MI, Boramanand N, Kapusta L, Crosson JE et al (2001) Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J Am Coll Cardiol 37(4):1129–1134
Boccalandro F, Velasco A, Thomas C, Richards B, Radovancevic B (2003) Relations among heart failure severity, left ventricular loading conditions, and repolarization length in advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92(5):544–547
Galinier M, Vialette JC, Fourcade J, Cabrol P, Dongay B, Massabuau P et al (1998) QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology. Eur Heart J 19(7):1054–1062
Towbin JA (1999) Pediatric myocardial disease. Pediatr Clin North Am 46(2):289–312, ix
Lamb HJ, Singleton RR, van der Geest RJ, Pohost GM, de Roos A (1995) MR imaging of regional cardiac function: low-pass filtering of wall thickness curves. Magn Reson Med 34(3):498–502
Prakash A, Powell AJ, Krishnamurthy R, Geva T (2004) Magnetic resonance imaging evaluation of myocardial perfusion and viability in congenital and acquired pediatric heart disease. Am J Cardiol 93(5):657–661
Kaufman J, Almodovar MC, Zuk J, Friesen RH (2008) Correlation of abdominal site near-infrared spectroscopy with gastric tonometry in infants following surgery for congenital heart disese. Pediatr Crit Care Med 9(1):62–68
Sullivan JE, Witte MK, Yamashita TS, Myers CM, Blumer JL (1996) Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants. Clin Pharmacol Ther 60(4):424–434
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 341(10):709–717
McDonald KM, D'Aloia A, Parrish T, Mock J, Hauer K, Stillman AE et al (1998) Functional impact of an increase in ventricular mass after myocardial damage and its attenuation by converting enzyme inhibition. J Card Fail 4(3):203–212
Nakamura H, Ishii M, Sugimura T, Chiba K, Kato H, Ishizaki T (1994) The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure. Clin Pharmacol Ther 56(2):160–168
(1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316(23):1429–35
(1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 325(5):293–302
Lewis AB, Chabot M (1993) The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy. Pediatr Cardiol 14(1):9–12
Montigny M, Davignon A, Fouron JC, Biron P, Fournier A, Elie R (1989) Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt. Am J Cardiol 63(9):631–633
Webster MW, Neutze JM, Calder AL (1992) Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts. Pediatr Cardiol 13(3):129–135
Leversha AM, Wilson NJ, Clarkson PM, Calder AL, Ramage MC, Neutze JM (1994) Efficacy and dosage of enalapril in congenital and acquired heart disease. Arch Dis Child 70(1):35–39
Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL et al (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-overall programme. Lancet 362(9386):759–766
McGowan FX Jr, Davis PJ, Siewers RD, del Nido PJ (1995) Coronary vasoconstriction mediated by endothelin-1 in neonates. Reversal by nitroglycerin. J Thorac Cardiovasc Surg 109(1):88–97, discussion 97–98
Kawamura M, Minamikawa O, Yokochi H, Maki S, Yasuda T, Mizukawa Y (1980) Combined use of phenoxybenzamine and dopamine for low cardiac output syndrome in children at withdrawal from cardiopulmonary bypass. Br Heart J 43(4):388–392
Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC et al (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7):996–1002
Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL (1995) Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 23(11):1907–1914
Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM et al (1991) Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325(21):1468–1475
Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR (1995) Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J Am Coll Cardiol 25(6):1225–1231
Packer M, Fowler MB, Roecker EB, Coats AJ, Katus HA, Krum H et al (2002) Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106(17):2194–2199
Krum H, Sackner-Bernstein JD, Goldsmith RL, Kukin ML, Schwartz B, Penn J et al (1995) Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 92(6):1499–1506
Shaddy KE, Boucek MM, Hsu OT, Boucek RJ, Canter CE, Mahony L et al (2007) Pediatric Carvedilol Group. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 12,298(10):1171–1179
Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE et al (1996) Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 94(11):2807–2816
Buchhorn R, Hulpke-Wette M, Hilgers R, Bartmus D, Wessel A, Bursch J (2001) Propranolol treatment of congestive heart failure in infants with congenital heart disease: the CHF-PRO-INFANT trial. Congestive heart failure in infants treated with propanol. Int J Cardiol 79(2–3):167–173
Ross RD (2001) Medical management of chronic heart failure in children. Am J Cardiovasc Drugs 1(1):37–44
Smith TW (1993) Digoxin in heart failure. N Engl J Med 329(1):51–53
Tauke J, Goldstein S, Gheorghiade M (1994) Digoxin for chronic heart failure: a review of the randomized controlled trials with special attention to the PROVED (Prospective Randomized Study of Ventricular Failure and the Efficacy of Digoxin) and RADIANCE (Randomized Assessment of Digoxin on Inhibitors of the Angiotensin Converting Enzyme) trials. Prog Cardiovasc Dis 37(1):49–58
(1997) The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 336(8):525–33
Mahle WT, Cuadrado AR, Kirshbom PM, Kanter KR, Simsic JM (2005) Nesiritide in infants and children with congestive heart failure. Pediatr Crit Care Med 6(5):543–546
Sehra R, Underwood K (2006) Nesiritide use for critically ill children awaiting cardiac transplantation. Pediatr Cardiol 27(1):47–50
Egan JR, Clarke AJ, Williams S, Cole AD, Ayer J, Jacobe S et al (2006) Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med 21(3):183–187
Namachivayam P, Crossland DS, Butt WW, Shekerdemian LS (2006) Early experience with levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med 7(5):445–448
Thatai D, Ahooja V, Pullicino PM (2006) Pharmacological prevention of thromboembolism in patients with left ventricular dysfunction. Am J Cardiovasc Drugs 6(1):41–49
Heymsfield SB, Smith J, Redd S, Whitworth HB Jr (1981) Nutritional support in cardiac failure. Surg Clin North Am 61(3):635–652
Akagi T, Benson LN, Lightfoot NE, Chin K, Wilson G, Freedom RM (1991) Natural history of dilated cardiomyopathy in children. Am Heart J 121(5):1502–1506
Canter CE, Shaddy RE, Bernstein D, Hsu DT, Chrisant MR, Kirklin JK et al (2007) Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 115(5):658–676
Lewis AB, Chabot M (1991) Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 68(4):365–369
Tsirka AE, Trinkaus K, Chen SC, Lipshultz SE, Towbin JA, Colan SD et al (2004) Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol 44(2):391–397
Calabrese F, Rigo E, Milanesi O, Boffa GM, Angelini A, Valente M et al (2002) Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol 11(4):212–221
English RF, Janosky JE, Ettedgui JA, Webber SA (2004) Outcomes for children with acute myocarditis. Cardiol Young 14(5):488–493
Lee KJ, McCrindle BW, Bohn DJ, Wilson GJ, Taylor GP, Freedom RM et al (1999) Clinical outcomes of acute myocarditis in childhood. Heart 82(2):226–233
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this entry
Cite this entry
Tissot, C., da Cruz, E.M., Miyamoto, S.D. (2014). Congestive Heart Failure. In: Da Cruz, E., Ivy, D., Jaggers, J. (eds) Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. Springer, London. https://doi.org/10.1007/978-1-4471-4619-3_229
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4619-3_229
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4618-6
Online ISBN: 978-1-4471-4619-3
eBook Packages: MedicineReference Module Medicine